Sébastien Debarbieux Selected Research

Sébastien Debarbieux Research Topics

4	Melanoma (Melanoma, Malignant) 05/2014 - 01/2008
3	Neoplasms (Cancer) 12/2021 - 01/2008
2	Sarcoidosis (Schaumann Disease) 01/2017 - 01/2017
1	Immune System Diseases (Immune Disorders) 12/2021
1	Dermatomyositis (Dermatopolymyositis) 12/2021
1	Scleromyxedema (Lichen Myxedematosus) 01/2020
1	Paraproteinemias (Monoclonal Gammopathy) 01/2020
1	Pemphigus (Pemphigus Vulgaris) 01/2020
1	Hidradenitis Suppurativa 06/2016
1	Stevens-Johnson Syndrome (Lyell's Syndrome) 11/2015
1	Skin Diseases (Skin Disease) 11/2015
1	Blister (Bulla) 11/2015
1	Dermatitis 11/2015
1	Necrosis 01/2015
1	Acrodermatitis (Gianotti Crosti Syndrome) 01/2015
1	Squamous Cell Carcinoma (Epidermoid Carcinoma) 01/2008
1	Skin Neoplasms (Skin Cancer) 01/2008
1	Basal Cell Carcinoma (Rodent Ulcer) 01/2008
1	Necrobiosis Lipoidica 01/2008
1	Keratoacanthoma 01/2008

3	Biological ProductsIBA 01/2020 - 01/2009
2	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2020 - 01/2017
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2017 - 01/2017
2	VemurafenibIBA 05/2014 - 04/2013
1	AutoantibodiesIBA 12/2021
1	DNA (Deoxyribonucleic Acid)IBA 12/2021
1	Rituximab (Mabthera)FDA Link 01/2020
1	CollagenIBA 01/2020
1	EnzymesIBA 01/2020
1	ImmunosorbentsIBA 01/2020
1	RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA 01/2020
1	Transforming Growth Factors (Transforming Growth Factor)IBA 01/2020
1	DesmogleinsIBA 01/2020
1	Pharmaceutical PreparationsIBA 01/2017
1	Infliximab (Remicade)FDA Link 01/2017
1	Immunosuppressive Agents (Immunosuppressants)IBA 01/2017
1	Dapsone FDA Link 11/2015
1	MucinsIBA 11/2015
1	Acitretin FDA Link 01/2015
1	Ustekinumab (CNTO 1275)FDA Link 01/2015
1	Interleukin 1 Receptor Antagonist Protein (Anakinra)FDA Link 01/2015
1	GD3 ganglioside (GD(3))IBA 01/2009
1	GangliosidesIBA 01/2009
1	GlycosphingolipidsIBA 01/2009
1	Biotin (Vitamin H)FDA Link 01/2009
1	AntibodiesIBA 01/2009
1	ParaffinIBA 01/2009
1	StreptavidinIBA 01/2009
1	Formaldehyde (Formol)FDA Link 01/2009
1	Antimalarials (Antimalarial Agents)IBA 01/2008